Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mesothelioma | 12 | 2024 | 807 | 3.450 |
Why?
|
Sarcoma | 14 | 2023 | 1786 | 2.090 |
Why?
|
Soft Tissue Neoplasms | 12 | 2024 | 1152 | 2.090 |
Why?
|
Lung Neoplasms | 27 | 2024 | 13262 | 2.090 |
Why?
|
Chondrosarcoma | 4 | 2023 | 296 | 1.740 |
Why?
|
Peritoneal Neoplasms | 7 | 2022 | 707 | 1.720 |
Why?
|
Pleural Neoplasms | 7 | 2024 | 609 | 1.700 |
Why?
|
Bone Neoplasms | 10 | 2024 | 2532 | 1.680 |
Why?
|
Immunohistochemistry | 24 | 2024 | 11071 | 1.670 |
Why?
|
Fibrosarcoma | 4 | 2024 | 308 | 1.670 |
Why?
|
Ubiquitin Thiolesterase | 9 | 2024 | 454 | 1.640 |
Why?
|
Sarcoma, Small Cell | 3 | 2022 | 17 | 1.550 |
Why?
|
Hemangiosarcoma | 2 | 2023 | 216 | 1.410 |
Why?
|
Hemangioendothelioma, Epithelioid | 2 | 2021 | 53 | 1.290 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 10 | 2023 | 5251 | 1.280 |
Why?
|
Histiocytic Sarcoma | 2 | 2019 | 41 | 1.200 |
Why?
|
Small Cell Lung Carcinoma | 4 | 2024 | 421 | 0.950 |
Why?
|
Luminescent Proteins | 5 | 2014 | 835 | 0.910 |
Why?
|
Pleura | 2 | 2023 | 244 | 0.900 |
Why?
|
Neurofibrosarcoma | 1 | 2023 | 26 | 0.890 |
Why?
|
Tumor Suppressor Proteins | 7 | 2024 | 2802 | 0.870 |
Why?
|
Osteosarcoma | 3 | 2024 | 897 | 0.850 |
Why?
|
Solitary Fibrous Tumor, Pleural | 2 | 2019 | 25 | 0.840 |
Why?
|
Solitary Fibrous Tumors | 1 | 2023 | 67 | 0.840 |
Why?
|
Peritoneum | 2 | 2022 | 224 | 0.830 |
Why?
|
Diagnosis, Differential | 21 | 2024 | 12965 | 0.820 |
Why?
|
Osteoblastoma | 1 | 2022 | 24 | 0.800 |
Why?
|
Gene Fusion | 3 | 2022 | 354 | 0.790 |
Why?
|
RNA-Binding Protein EWS | 2 | 2021 | 210 | 0.790 |
Why?
|
Neoplasms, Vascular Tissue | 1 | 2021 | 25 | 0.790 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2022 | 70 | 0.770 |
Why?
|
Chordoma | 2 | 2023 | 346 | 0.750 |
Why?
|
Bone Cysts | 1 | 2021 | 48 | 0.750 |
Why?
|
NAD | 3 | 2017 | 609 | 0.740 |
Why?
|
Homeodomain Proteins | 4 | 2021 | 2414 | 0.740 |
Why?
|
Neurilemmoma | 2 | 2023 | 523 | 0.740 |
Why?
|
Negative-Pressure Wound Therapy | 4 | 2024 | 153 | 0.730 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2022 | 117 | 0.730 |
Why?
|
Transcription Factors | 9 | 2023 | 12103 | 0.700 |
Why?
|
Cytosol | 3 | 2016 | 887 | 0.690 |
Why?
|
Vascular Neoplasms | 1 | 2021 | 167 | 0.690 |
Why?
|
Cell Dedifferentiation | 1 | 2020 | 122 | 0.680 |
Why?
|
Humerus | 1 | 2021 | 269 | 0.650 |
Why?
|
NFATC Transcription Factors | 1 | 2021 | 381 | 0.640 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2019 | 62 | 0.640 |
Why?
|
Fibula | 1 | 2021 | 265 | 0.630 |
Why?
|
Hemangioma | 1 | 2023 | 728 | 0.620 |
Why?
|
Lipoma | 1 | 2020 | 292 | 0.600 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2020 | 368 | 0.590 |
Why?
|
Liposarcoma | 1 | 2020 | 283 | 0.580 |
Why?
|
Receptor, trkA | 1 | 2018 | 159 | 0.580 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2018 | 325 | 0.580 |
Why?
|
Myofibroma | 1 | 2017 | 45 | 0.570 |
Why?
|
Carcinoma, Small Cell | 1 | 2019 | 416 | 0.570 |
Why?
|
Biosensing Techniques | 4 | 2014 | 677 | 0.560 |
Why?
|
Glycolysis | 4 | 2017 | 828 | 0.560 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 184 | 0.550 |
Why?
|
Adenovirus E1A Proteins | 1 | 2016 | 73 | 0.550 |
Why?
|
Neoplasm Proteins | 5 | 2022 | 3610 | 0.530 |
Why?
|
In Situ Hybridization | 1 | 2020 | 1900 | 0.530 |
Why?
|
Endocrine System Diseases | 1 | 2018 | 250 | 0.520 |
Why?
|
Neuroendocrine Tumors | 2 | 2019 | 650 | 0.520 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2023 | 1613 | 0.510 |
Why?
|
WT1 Proteins | 1 | 2016 | 184 | 0.510 |
Why?
|
Scapula | 1 | 2017 | 173 | 0.510 |
Why?
|
Salivary Gland Neoplasms | 1 | 2019 | 304 | 0.500 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2021 | 3616 | 0.500 |
Why?
|
Neuroblastoma | 3 | 2018 | 1252 | 0.490 |
Why?
|
Femur | 1 | 2021 | 1302 | 0.480 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2017 | 586 | 0.470 |
Why?
|
Humans | 105 | 2024 | 760621 | 0.460 |
Why?
|
Nuclear Proteins | 5 | 2022 | 5791 | 0.450 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2017 | 329 | 0.450 |
Why?
|
Antigens, CD | 2 | 2021 | 4000 | 0.440 |
Why?
|
Lung Diseases, Interstitial | 2 | 2019 | 911 | 0.430 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2019 | 502 | 0.420 |
Why?
|
Carcinoma | 2 | 2022 | 2331 | 0.420 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2017 | 2864 | 0.420 |
Why?
|
Mutation | 14 | 2024 | 29932 | 0.400 |
Why?
|
Translocation, Genetic | 1 | 2018 | 1388 | 0.400 |
Why?
|
Lung | 8 | 2023 | 9994 | 0.380 |
Why?
|
Thymus Neoplasms | 2 | 2024 | 274 | 0.370 |
Why?
|
Aged | 36 | 2024 | 169152 | 0.360 |
Why?
|
Epithelial Cells | 4 | 2021 | 3663 | 0.360 |
Why?
|
Middle Aged | 39 | 2024 | 220352 | 0.350 |
Why?
|
Protein Engineering | 1 | 2014 | 541 | 0.350 |
Why?
|
Chondroblastoma | 2 | 2020 | 48 | 0.350 |
Why?
|
Young Adult | 21 | 2024 | 58741 | 0.350 |
Why?
|
Fractures, Bone | 1 | 2022 | 2041 | 0.340 |
Why?
|
Adult | 38 | 2024 | 219994 | 0.340 |
Why?
|
Radiology | 1 | 2023 | 2102 | 0.340 |
Why?
|
Molecular Imaging | 2 | 2014 | 818 | 0.330 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 2448 | 0.320 |
Why?
|
DNA-Binding Proteins | 4 | 2022 | 9585 | 0.320 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2023 | 626 | 0.320 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2021 | 4024 | 0.320 |
Why?
|
Female | 48 | 2024 | 391270 | 0.320 |
Why?
|
Male | 44 | 2024 | 359744 | 0.310 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1439 | 0.300 |
Why?
|
Gene Amplification | 2 | 2024 | 1085 | 0.290 |
Why?
|
Histone-Lysine N-Methyltransferase | 3 | 2020 | 678 | 0.290 |
Why?
|
Thyroid Neoplasms | 2 | 2018 | 2332 | 0.290 |
Why?
|
Proto-Oncogene Proteins | 2 | 2017 | 4490 | 0.290 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6315 | 0.280 |
Why?
|
Prognosis | 11 | 2023 | 29658 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2019 | 311 | 0.280 |
Why?
|
Energy Metabolism | 1 | 2017 | 2869 | 0.270 |
Why?
|
Aged, 80 and over | 18 | 2024 | 58995 | 0.260 |
Why?
|
Adolescent | 17 | 2024 | 87810 | 0.260 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2024 | 2506 | 0.250 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2543 | 0.250 |
Why?
|
Neoplasms, Mesothelial | 1 | 2024 | 3 | 0.240 |
Why?
|
Carcinoma, Papillary | 2 | 2021 | 785 | 0.230 |
Why?
|
Biopsy | 4 | 2020 | 6771 | 0.230 |
Why?
|
Osteomalacia | 1 | 2024 | 56 | 0.230 |
Why?
|
Octamer Transcription Factors | 1 | 2023 | 18 | 0.230 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.220 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2024 | 55 | 0.220 |
Why?
|
Myositis Ossificans | 1 | 2024 | 77 | 0.220 |
Why?
|
Child | 14 | 2024 | 79806 | 0.210 |
Why?
|
Fibromatosis, Aggressive | 1 | 2024 | 125 | 0.210 |
Why?
|
Haploidy | 1 | 2022 | 133 | 0.210 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2022 | 1596 | 0.210 |
Why?
|
Sarcoma, Synovial | 1 | 2023 | 151 | 0.200 |
Why?
|
Mediastinum | 1 | 2023 | 266 | 0.200 |
Why?
|
Receptors, Steroid | 1 | 2022 | 154 | 0.200 |
Why?
|
Indocyanine Green | 1 | 2023 | 236 | 0.200 |
Why?
|
Thymoma | 1 | 2023 | 187 | 0.190 |
Why?
|
Cell Line, Tumor | 8 | 2023 | 16939 | 0.190 |
Why?
|
Acetonitriles | 1 | 2021 | 54 | 0.190 |
Why?
|
Pathology, Molecular | 1 | 2024 | 329 | 0.190 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.190 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4319 | 0.190 |
Why?
|
Pneumonia | 2 | 2023 | 2131 | 0.190 |
Why?
|
Repressor Proteins | 4 | 2022 | 2981 | 0.190 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2022 | 307 | 0.190 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2024 | 5253 | 0.180 |
Why?
|
Thoracic Diseases | 1 | 2021 | 99 | 0.180 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 174 | 0.180 |
Why?
|
Oncogene Fusion | 1 | 2020 | 81 | 0.170 |
Why?
|
Skull Base Neoplasms | 1 | 2023 | 269 | 0.170 |
Why?
|
Vulvar Neoplasms | 1 | 2022 | 263 | 0.170 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2024 | 487 | 0.170 |
Why?
|
Chondroma | 1 | 2020 | 53 | 0.170 |
Why?
|
Human papillomavirus 6 | 1 | 2019 | 16 | 0.170 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2021 | 167 | 0.170 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2019 | 44 | 0.170 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11903 | 0.170 |
Why?
|
Thymus Gland | 1 | 2024 | 1247 | 0.160 |
Why?
|
Florida | 1 | 2020 | 430 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2022 | 9276 | 0.160 |
Why?
|
Cysts | 1 | 2024 | 683 | 0.160 |
Why?
|
beta Catenin | 1 | 2024 | 1043 | 0.160 |
Why?
|
Epigenomics | 1 | 2024 | 936 | 0.160 |
Why?
|
Neurofibromin 2 | 1 | 2019 | 270 | 0.150 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2018 | 119 | 0.150 |
Why?
|
Sirtuin 3 | 1 | 2018 | 68 | 0.150 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2022 | 479 | 0.150 |
Why?
|
Horses | 1 | 2018 | 298 | 0.150 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 301 | 0.150 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 264 | 0.140 |
Why?
|
Polymers | 2 | 2023 | 1621 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2019 | 225 | 0.140 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2018 | 77 | 0.140 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2023 | 1139 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2023 | 8515 | 0.140 |
Why?
|
Hematologic Diseases | 1 | 2021 | 496 | 0.140 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2021 | 517 | 0.140 |
Why?
|
Child, Preschool | 5 | 2023 | 42063 | 0.140 |
Why?
|
Pharmaceutical Preparations | 2 | 2022 | 1091 | 0.140 |
Why?
|
Thoracic Surgical Procedures | 1 | 2020 | 348 | 0.140 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 448 | 0.140 |
Why?
|
Oxidation-Reduction | 2 | 2014 | 2222 | 0.140 |
Why?
|
Fructose-Bisphosphate Aldolase | 1 | 2016 | 51 | 0.130 |
Why?
|
Chromosome Aberrations | 1 | 2022 | 1764 | 0.130 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 698 | 0.130 |
Why?
|
Recurrence | 3 | 2024 | 8482 | 0.130 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2024 | 2782 | 0.130 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1088 | 0.130 |
Why?
|
Paraganglioma | 1 | 2017 | 142 | 0.130 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 282 | 0.130 |
Why?
|
Anus Neoplasms | 1 | 2019 | 329 | 0.130 |
Why?
|
Cell Nucleus | 3 | 2020 | 2907 | 0.130 |
Why?
|
src-Family Kinases | 1 | 2018 | 535 | 0.130 |
Why?
|
Retrospective Studies | 15 | 2024 | 80372 | 0.120 |
Why?
|
Pheochromocytoma | 1 | 2017 | 328 | 0.120 |
Why?
|
Sensitivity and Specificity | 4 | 2024 | 14660 | 0.120 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2014 | 15 | 0.120 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2016 | 232 | 0.120 |
Why?
|
Wilms Tumor | 1 | 2017 | 375 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 270 | 0.120 |
Why?
|
Oncogene Proteins | 1 | 2018 | 719 | 0.120 |
Why?
|
Respiratory Tract Infections | 1 | 2022 | 1007 | 0.120 |
Why?
|
Pathology, Clinical | 1 | 2018 | 375 | 0.120 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2014 | 412 | 0.120 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2017 | 600 | 0.120 |
Why?
|
Immunophenotyping | 1 | 2019 | 1871 | 0.120 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2821 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1182 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2919 | 0.110 |
Why?
|
Incidental Findings | 1 | 2019 | 698 | 0.110 |
Why?
|
Piperazines | 2 | 2021 | 2525 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1728 | 0.110 |
Why?
|
DNA Helicases | 1 | 2018 | 854 | 0.110 |
Why?
|
Phenotype | 3 | 2020 | 16546 | 0.110 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4107 | 0.110 |
Why?
|
Meningioma | 1 | 2022 | 1221 | 0.110 |
Why?
|
Pyruvic Acid | 1 | 2014 | 195 | 0.110 |
Why?
|
Infant | 4 | 2023 | 36060 | 0.100 |
Why?
|
Meningeal Neoplasms | 1 | 2022 | 1249 | 0.100 |
Why?
|
Mice | 12 | 2024 | 81208 | 0.100 |
Why?
|
Genomics | 3 | 2022 | 5794 | 0.100 |
Why?
|
Neck | 1 | 2017 | 731 | 0.100 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2019 | 800 | 0.100 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3844 | 0.100 |
Why?
|
Up-Regulation | 1 | 2021 | 4122 | 0.100 |
Why?
|
Bone and Bones | 1 | 2022 | 2560 | 0.100 |
Why?
|
Adenoma | 1 | 2022 | 2148 | 0.100 |
Why?
|
Trans-Activators | 2 | 2022 | 2860 | 0.100 |
Why?
|
Lactic Acid | 2 | 2014 | 1134 | 0.100 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2017 | 733 | 0.100 |
Why?
|
Gene Deletion | 1 | 2019 | 2668 | 0.100 |
Why?
|
Animals | 15 | 2024 | 167963 | 0.100 |
Why?
|
Calibration | 1 | 2014 | 816 | 0.090 |
Why?
|
Paclitaxel | 3 | 2023 | 1736 | 0.090 |
Why?
|
Bone Marrow | 1 | 2021 | 2912 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2023 | 3539 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 1607 | 0.090 |
Why?
|
Nanoparticles | 1 | 2022 | 1943 | 0.090 |
Why?
|
Thoracic Surgery, Video-Assisted | 2 | 2023 | 277 | 0.090 |
Why?
|
Intracellular Space | 1 | 2011 | 197 | 0.090 |
Why?
|
RNA | 1 | 2020 | 2722 | 0.090 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2011 | 2502 | 0.090 |
Why?
|
Zebrafish Proteins | 1 | 2016 | 1006 | 0.080 |
Why?
|
Neoplasms | 3 | 2023 | 22072 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11712 | 0.080 |
Why?
|
Influenza, Human | 1 | 2020 | 1528 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2024 | 3584 | 0.080 |
Why?
|
Pyrimidines | 1 | 2021 | 3016 | 0.080 |
Why?
|
Archaeal Proteins | 1 | 2009 | 57 | 0.080 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3758 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4573 | 0.080 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2380 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15289 | 0.080 |
Why?
|
Fluorescent Dyes | 2 | 2023 | 1913 | 0.080 |
Why?
|
Survival Analysis | 2 | 2019 | 10182 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17790 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4550 | 0.080 |
Why?
|
Adenosine Diphosphate | 1 | 2009 | 429 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2825 | 0.070 |
Why?
|
Boston | 1 | 2020 | 9280 | 0.070 |
Why?
|
Workflow | 2 | 2022 | 852 | 0.070 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2019 | 2003 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1894 | 0.070 |
Why?
|
Bacterial Proteins | 2 | 2011 | 3826 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2024 | 65017 | 0.070 |
Why?
|
Cell Survival | 2 | 2014 | 5797 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2019 | 2276 | 0.070 |
Why?
|
Cell Movement | 1 | 2018 | 5206 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4713 | 0.070 |
Why?
|
Cell Line | 2 | 2017 | 15620 | 0.060 |
Why?
|
Platelet Count | 1 | 2008 | 777 | 0.060 |
Why?
|
Genetic Engineering | 1 | 2011 | 933 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4878 | 0.060 |
Why?
|
Body Water | 1 | 2006 | 341 | 0.060 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2024 | 36 | 0.060 |
Why?
|
Mesenchymoma | 1 | 2024 | 49 | 0.060 |
Why?
|
Peritoneal Diseases | 1 | 2024 | 76 | 0.060 |
Why?
|
Surgical Wound Infection | 2 | 2024 | 1527 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2024 | 2828 | 0.060 |
Why?
|
Hypophosphatemia | 1 | 2024 | 93 | 0.050 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 2022 | 35 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2011 | 3735 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5649 | 0.050 |
Why?
|
Tumor Burden | 2 | 2019 | 1895 | 0.050 |
Why?
|
Adenosine Triphosphate | 1 | 2009 | 1993 | 0.050 |
Why?
|
Paraneoplastic Syndromes | 1 | 2024 | 155 | 0.050 |
Why?
|
Receptors, Thyroid Hormone | 1 | 2022 | 199 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9185 | 0.050 |
Why?
|
Mesentery | 1 | 2022 | 202 | 0.050 |
Why?
|
Pancreatitis | 1 | 2009 | 1100 | 0.050 |
Why?
|
Neoplasm Staging | 3 | 2023 | 11152 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10446 | 0.050 |
Why?
|
Porosity | 1 | 2022 | 349 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2023 | 6828 | 0.050 |
Why?
|
Dairy Products | 1 | 2005 | 494 | 0.050 |
Why?
|
Protons | 2 | 2023 | 1114 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6853 | 0.050 |
Why?
|
Tropolone | 1 | 2021 | 10 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3618 | 0.050 |
Why?
|
Fluorescence | 1 | 2023 | 751 | 0.050 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3446 | 0.050 |
Why?
|
Pancreatic Neoplasms | 2 | 2009 | 5351 | 0.050 |
Why?
|
Collagen Type I | 1 | 2024 | 616 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4312 | 0.050 |
Why?
|
Skull Base | 1 | 2023 | 291 | 0.050 |
Why?
|
Mitotic Index | 1 | 2020 | 161 | 0.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2009 | 1724 | 0.040 |
Why?
|
Gadolinium | 1 | 2005 | 959 | 0.040 |
Why?
|
Epithelioid Cells | 1 | 2020 | 60 | 0.040 |
Why?
|
Drug Delivery Systems | 2 | 2021 | 2221 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 653 | 0.040 |
Why?
|
Surgical Mesh | 1 | 2022 | 311 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2022 | 317 | 0.040 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2019 | 40 | 0.040 |
Why?
|
Appendiceal Neoplasms | 1 | 2021 | 155 | 0.040 |
Why?
|
Water | 1 | 2005 | 1407 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2021 | 384 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2024 | 995 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1612 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2022 | 1837 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 2021 | 924 | 0.040 |
Why?
|
Autopsy | 1 | 2021 | 1007 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2017 | 26181 | 0.040 |
Why?
|
Adrenalectomy | 1 | 2019 | 348 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 383 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2005 | 2512 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 1617 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20080 | 0.030 |
Why?
|
Pneumonectomy | 1 | 2023 | 1111 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2021 | 1069 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 4 | 2024 | 20509 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2011 | 18957 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 730 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 551 | 0.030 |
Why?
|
Pyrazines | 1 | 2021 | 1199 | 0.030 |
Why?
|
Image Enhancement | 1 | 2006 | 2881 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1122 | 0.030 |
Why?
|
Computational Biology | 2 | 2019 | 3505 | 0.030 |
Why?
|
Fructosediphosphates | 1 | 2014 | 24 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3113 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2021 | 1273 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2005 | 0.030 |
Why?
|
Glucose Transport Proteins, Facilitative | 1 | 2014 | 57 | 0.030 |
Why?
|
Lipids | 1 | 2005 | 3336 | 0.030 |
Why?
|
Cystectomy | 1 | 2019 | 697 | 0.030 |
Why?
|
Forecasting | 1 | 2023 | 2932 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2018 | 21025 | 0.030 |
Why?
|
Myocarditis | 1 | 2021 | 766 | 0.030 |
Why?
|
Protein Conformation | 1 | 2021 | 3969 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2014 | 402 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2006 | 3340 | 0.030 |
Why?
|
Wound Healing | 1 | 2024 | 2788 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36290 | 0.030 |
Why?
|
Signal Transduction | 2 | 2016 | 23376 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2018 | 3602 | 0.030 |
Why?
|
Models, Chemical | 1 | 2014 | 614 | 0.030 |
Why?
|
Sulfonamides | 1 | 2021 | 1977 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2053 | 0.020 |
Why?
|
Cytoskeleton | 1 | 2016 | 1167 | 0.020 |
Why?
|
Pyrazoles | 1 | 2021 | 1999 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2313 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18137 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2138 | 0.020 |
Why?
|
Prostatectomy | 1 | 2019 | 1956 | 0.020 |
Why?
|
DNA Methylation | 1 | 2024 | 4373 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2725 | 0.020 |
Why?
|
Histones | 1 | 2020 | 2583 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2879 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2012 | 419 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 2011 | 687 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2014 | 1257 | 0.020 |
Why?
|
Pain | 1 | 2024 | 5066 | 0.020 |
Why?
|
Echocardiography | 1 | 2021 | 4981 | 0.020 |
Why?
|
Cohort Studies | 3 | 2018 | 41335 | 0.020 |
Why?
|
Myocardium | 1 | 2021 | 4700 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4166 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6414 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4902 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3696 | 0.020 |
Why?
|
Mutagenesis | 1 | 2011 | 1234 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2192 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11481 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5643 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2006 | 361 | 0.020 |
Why?
|
Carrier State | 1 | 2009 | 525 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 13981 | 0.020 |
Why?
|
Anticoagulants | 1 | 2021 | 4897 | 0.020 |
Why?
|
Metabolomics | 1 | 2014 | 1628 | 0.020 |
Why?
|
Siblings | 1 | 2009 | 824 | 0.020 |
Why?
|
Brain | 1 | 2012 | 26951 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5325 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2009 | 1456 | 0.010 |
Why?
|
Pancreatectomy | 1 | 2008 | 810 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8313 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2006 | 11345 | 0.010 |
Why?
|
Nonlinear Dynamics | 1 | 2005 | 494 | 0.010 |
Why?
|
Glucose | 1 | 2014 | 4351 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2023 | 39261 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2009 | 2651 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2024 | 15697 | 0.010 |
Why?
|
Pedigree | 1 | 2009 | 4578 | 0.010 |
Why?
|
Insulin | 1 | 2016 | 6597 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6048 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6068 | 0.010 |
Why?
|
Preoperative Care | 1 | 2008 | 2256 | 0.010 |
Why?
|
Family | 1 | 2009 | 3189 | 0.010 |
Why?
|
Prostate | 1 | 2006 | 1793 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2009 | 4013 | 0.010 |
Why?
|
Computer Simulation | 1 | 2006 | 6218 | 0.010 |
Why?
|
Contrast Media | 1 | 2005 | 5305 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9467 | 0.010 |
Why?
|